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RESEARCH ARTICLE
Spire-1 contributes to the invadosome and its associated
invasive properties
Vanessa Lagal1,2,3, Marie Abrivard1,2,3, Virginie Gonzalez1,2,3, Audrey Perazzi1,2,3, Sonam Popli1,2,3,
Elodie Verzeroli1,2,3 and Isabelle Tardieux1,2,3,*
ABSTRACT
Cancer cells have an increased ability to squeeze through
extracellular matrix gaps that they create by promoting proteolysis
of its components. Major sites of degradation are specialized micro-
domains in the plasma membrane collectively named invadosomes
where the Arp2/3 complex and formin proteins cooperate to spatio-
temporally control actin nucleation and the folding of a dynamic F-
actin core. At invadosomes, proper coupling of exo-endocytosis
allows polarized delivery of proteases that facilitate degradation of
ECM and disruption of the cellular barrier. We investigated the
contribution of the actin nucleator Spire-1 to invadosome structure
and function, using Src-activated cells and cancer cells. We found
that Spire-1 is specifically recruited at invadosomes and is part of a
multi-molecular complex containing Src kinase, the formin mDia1
and actin. Spire-1 interacts with the Rab3A GTPase, a key player in
the regulation of exocytosis that is present at invadosomes. Finally,
over- and under-expression of Spire-1 resulted in cells with
an increased or decreased potential for matrix degradation,
respectively, therefore suggesting a functional interplay of Spire-1
with both actin nucleation and vesicular trafficking that might impact
on cell invasive and metastatic behavior.
KEY WORDS: Spire-1, Actin, Invadosome, Src-activated 3T3,
Gelatin invasion, Endothelial transmigration, Vesicular trafficking
INTRODUCTION
Whereas cells from myeloid and lymphoid lineages are typically
endowed with the physiological capability to glide through the
extracellular matrix (ECM) network and to cross endothelia to
fulfil their functions, tumor cells in general have gained similar
abilities as they squeeze through ECM gaps and endothelia and
eventually infiltrate tissues. Whether constitutive or adaptive,
these processes are often, although not always, associated with
local proteolysis of the surrounding matrix (Sabeh et al., 2009;
Linder et al., 2011; Wolf and Friedl, 2011). Major sites of matrix
degradation are specialized mechano-sensitive membrane micro-
domains that adhere to the substratum: these are either called
invadopodia or podosomes depending whether they form in
cancer cells or in myeloid-derived and v-Src-transformed cells,
respectively and are collectively termed invadosomes (Linder,
2007; Parekh and Weaver, 2009; Weaver, 2008). Indeed,
expression of the constitutively active Src oncogene induces
transcription of genes whose products have been implicated in
tumor cell growth and metastatic properties (Irby and Yeatman,
2000). Chief among these products is the Src family kinase itself,
which drives the remodeling of the actin cytoskeleton from stress
fibers to podosomes (Tarone et al., 1985; Destaing et al., 2010;
Cougoule et al., 2010; Boateng et al., 2012).
Actin nucleation plays a central role in promoting the
multipartite architecture of all types of invadosomes. A core of
dynamic F-actin bundles folds under the tight control of actin-
nucleating and -elongation factors and actin-related signaling
proteins (Albiges-Rizo et al., 2009; Dovas et al., 2009; Sibony-
Benyamini and Gil-Henn, 2012). Within this core, synergistic
activation of N-WASP and cortactin promotes continuous
stimulation of the Arp2/3 complex to nucleate branched actin
daughter filaments. Recently, a second class of actin nucleators
composed of the DRF/mDia1-3 (human/mouse) formins have been
shown to cooperate with the Arp2/3 complex during invadosome
biogenesis and to selectively localize at invadosomes in primary
macrophages (Liza´rraga et al., 2009; Mersich et al., 2010). Finally,
invadosomes can self-organize into dynamic clusters or rosettes by
building up a network of radial actin filaments that connects
individual structures to each other (Albiges-Rizo et al., 2009;
Destaing et al., 2010; Linder et al., 2011).
The proteolytic and pro-invasive properties of invadosomes are
supported by intense polarized vesicular traffic with the endocytic
and exocytic pathways locally converging and promoting
delivery of ECM lytic enzymes. The large family of soluble
and membrane-associated zinc-dependent metalloproteases (MT-
MMPs), together with additional proteolytic enzymes, direct a
diffuse and/or cell-surface-restricted lysis of the ECM (Egeblad
and Werb, 2002; Caldieri and Buccione, 2010; Linder et al.,
2011). Consequently, the membrane fusion machinery that
regulates exocytosis is functionally required for ECM
degradation and invasion (Steffen et al., 2008). However, there
is increasing evidence that actin nucleation ensures correct
membrane trafficking along the endocytic or exocytic pathways
(Kaksonen et al., 2006; Soldati and Schliwa, 2006; Morel et al.,
2009) and the Arp2/3 regulatory partner N-WASP has been
shown to promote delivery and stabilization of MTP1-MMP at
invasive pseudopodia in 3D matrices (Yu et al., 2012).
Spire proteins not only belong to a class of actin nucleators
(Quinlan et al., 2005; Renault et al., 2008; Firat-Karalar and
Welch, 2011) but have also been assigned a role in vesicular
trafficking, in particular from the TGN to the plasma membrane
(Quinlan et al., 2005; Kerkhoff et al., 2001). More recently, a
fascinating study has revealed that Spire protein in concert with
formin can organize a newly identified network that connects
cytoplasmic vesicles to each other and drives their long range and
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polarized transport to the plasma membrane (Schuh, 2011).
Therefore, we investigated whether, in mammalian cells, Spire
could contribute to invadosome structure and function. Spire
proteins, including human Spire-1 and Spire-2, all display a
conserved modular structure with a N-terminally located kinase
non catalytic C-lobe domain (KIND) followed by a central cluster
of four G-actin binding Wiskott–Aldrich syndrome protein
homology domain 2 (WH2) modules powering the actin-
nucleating activity. The C-terminal region contains: (1) a
‘Spire-box’ with sequence similarity to a helical domain of
rabphilin-3A; and (2) a zinc finger structure that is highly
homologous to the membrane-binding FYVE motif; both motifs
are reported to be responsible for targeting of Spire-1 to
intracellular membranes (Kerkhoff et al., 2001; Kerkhoff, 2006).
We found a significant upregulation of Spire-1 expression in Src-
activated fibroblasts and pre-osteoclasts, two prototypes of
invadosome-forming cells. Both endogenous and exogenous Spire-
1 accumulated at invadosomes and at rosettes or rings, a localization
that fits with the detection of Spire-1 within a multi-molecular
complex also containing bona fide invadosome components such as
the phosphorylated Src kinase (pY418-Src), the formin mDia1 and
F-actin. Spire-1 also localized to cytoplasmic vesicles whose traffic
towards invadosomes might involve the GTPase Rab3A because we
show a partnership between the two molecules in cells and in vitro.
Because modulation of Spire-1 expression impacts cell proteolytic
and pro-invasive properties, our data support a tight interplay
between three types of actin nucleators during fine-tuning of
invadosome function and newly highlight Spire-1 as one player that
possibly couples actin nucleation and vesicular trafficking during
invadosome function.
RESULTS
Spire-1 expression is enhanced in Src-transformed cells and is
detected at invadosomes or rings
Because expression of Spire-1 is reported to be tissue-restricted,
with a prominence in embryonic and adult brain cells, we first
verified whether Spire-1 was expressed in cells characterized by
their high number of invadosomes. Following RNA extraction,
RT-PCR assays were carried out using pairs of primers that
discriminate between Spire1 and Spire2 sequences (see Materials
and Methods). A single 1123 bp PCR product was detected in
parental and Src-activated (3T3-Src+) mouse 3T3 fibroblasts or in
Src-activated mouse pre-osteoclasts (pre-Ost-Src+) that was
barely distinguishable in 3T3 mouse parental fibroblasts (3T3-
WT; Fig. 1A). The identity of the PCR product as Spire1 was
confirmed by nucleotide sequencing (data not shown). We found
that the amount of these transcripts is significantly enhanced in
Src+ when compared with wild-type (WT) cells (about six- to
eightfold, Fig. 1A). To quantify and localize Spire-1 protein in
situ in Src+ cells, we first checked for the specificity of
commercial antibodies raised against the Spire-1 internal region
(K19). Using SDS-PAGE and western blotting, we analyzed
whole-cell extracts from HEK-293 cells expressing endogenous
Spire-1, and we detected a single product at the expected size, for
which signal intensity correlated with the amounts of extracts
(black labels, Fig. 1B). When HEK-293 cells ectopically
expressed Myc-Spire-1 fusion protein (red labels, Fig. 1B), the
K19 antibodies recognized several products equally detected by
anti-Myc antibodies. Antibody specificity was further confirmed
with the loss of signal in cells silenced for Spire-1 (supplementary
materia Fig. S1). We next analyzed cell extracts from the
different cell lines of interest at two protein concentrations and
we observed a,threefold increase in Src+ cells when compared with
3T3-WT cells (Fig. 1C). However, because these antibodies appeared
ineffective for in situ analysis, we generated antibodies raised against
the recombinant Spire-1 N-KIND-terminal polypeptide (N-KIND;
supplementary material Table S1). As expected, these antibodies
detected endogenous Spire-1 and exogenous Myc-Spire-1 in HEK293
total cell extracts (Fig. 1B, right). When used in situ on 3T3-Src+cells,
these antibodies labeled ring-shaped structures at the cell periphery
that resembled invadosomes and rosettes (Fig. 1D, white arrows). Co-
staining of F-actin that typically accumulates in those structures
supported the presence of Spire-1 at individual (arrowheads) and
clustered (arrows) invadosomes (Fig. 1E).
Spire-1 is selectively recruited to invadosomes and is part of a multi-
molecular complex containing mDia1, actin and the pY418-Src kinase
We next analyzed the distribution of endogenous Spire-1 in more
detail with regards to additional bona fide invadosome
components. Because Spire-1 fusion proteins proved useful for
unravelling how Spire-1 participates in endosome biogenesis
(Morel et al., 2009) and since endogenous and Myc-tagged Spire-
1 signals overlapped in 3T3-Src+ cells (supplementary material
Fig. S2A, green and red arrows), we included samples of cells
expressing GFP or Myc-tagged Spire-1 in the study.
In 3T3-Src+ cells, whereas endogenous Spire-1 displayed a
punctate cytoplasmic pattern in line with previous work reporting
the distribution of exogenous p150-Spire protein (Kerkhoff et al.,
2001), it also markedly associated with peripherally located
invadosomes that were unambiguously identified by the co-
labeling of cortactin and F-actin (Artym et al., 2006) (Fig. 2A;
supplementary material Fig. S2B). A similar overlap was
observed between Myc-Spire-1 (arrows), Cortactin and F-actin
in transfected 3T3-Src+ cells [Fig. 2B,C, see insets and Pearson’s
colocalization coefficients (Bolte and Cordelie`res, 2006)] and
was also found with the GFP-Spire-1 fusion protein
(supplementary material Fig. S2C). Another key component of
the invadosomes, the pY418-Src kinase was seen decorating the
edges of Myc-Spire-1-labeled invadosomes and rosettes (see
arrows and the zoomed area, Fig. 2D). Finally, using affinity pull-
down assays to co-precipitate Myc-Spire-1 with binding partners
from 3T3-Src+ cells, we found Myc-Spire-1 in a complex
containing not only actin and pY418-Src but also the formin
mDia1 (n.4 independent experiments) (Fig. 2E). Interestingly,
neither Arp2/3 nor cortactin was detected within the Spire-1
multi-molecular complex under our conditions. Because mDia1
and endogenous Spire-1 were observed as distinct populations in
the 3T3-Src+ cell cytoplasm in contrast to invadosomes or ring
sites (Fig. 2F; supplementary material Fig. S2E, see also higher-
magnification insets and Pearson’s coefficient), our data suggest a
novel interplay between Spire-1 and mDia1 that is independent of
the Arp2/3 actin-nucleating complex – specifically at invadosome
sites. This observation agrees well with previous and recent
reports of the cooperation of Spire-1 and formin during
asymmetric division of Drosophila and mouse oocytes (Quinlan
et al., 2007; Vizcarra et al., 2011; Pfender et al., 2011).
The Spire-1 WH2 domain targets Spire-1 to invadosomes
Because in situ and biochemical data pointed to Spire-1 as an
actin partner protein at invadosomes, we next tested whether the
four WH2 modules that confer the actin-nucleating property
would control targeting of Spire-1 to invadosomes. To this end,
we analyzed the subcellular distribution of transiently expressed
truncated Spire-1 proteins with or without the WH2 domain in
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 328–340 doi:10.1242/jcs.130161
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Src+ fibroblasts (see schematic representation of the constructs
supplementary material Fig. S3A). Invadosomes were detected
using Phalloidin staining of their F-actin cores as exemplified
with full-length Myc-Spire-1 (Fig. 3A). When the N-terminal
KIND (N-KIND) domain was expressed alone, it was distributed
in a more diffuse cytoplasmic pattern than full-length Spire-1 and
only ,22% of cells showed a modest enrichment of the Myc-N-
KIND polypeptide at invadosomes (n5300 cells) (Fig. 3B,
supplementary material Fig. S3B). By contrast, the N-KIND
WH2 domain was systematically enriched at invadosomes
(n5250 cells, Fig. 3C, supplementary material Fig. S3C).
Whereas the Myc-C-terminal Spire-1 (Myc-Cter) polypeptide
displayed a vesicular pattern similar to Spire-1 and it localized at
invadosome sites in less than 5% of the cells (n5250 cells)
(Fig. 3D). However, the addition of the WH2 domain promoted a
striking accumulation of the polypeptide at all invadosomes for
all the cells screened (n5250, Fig. 3E, supplementary material
Fig. S3D). Of note, similar results were obtained when the Myc
tag was replaced by an HA tag fused to the C-terminal (Cter)
polypeptide (less than 3% HA-positive invadosomes, n5200,
supplementary material Fig. S3E). These data indicate that the
WH2 domain drives Spire-1 at invadosomes. Interestingly, a
highly significant increase in the number of invadosomes and
rosettes was only associated with cells expressing Myc-WH2
when compared with cells expressing Myc-Spire-1 or mock-
transfected cells (Ct) (Fig. 3F, see arrows; Fig. 3G, Student’s t-
test, P,0.01). Surprisingly, when the recombinant polypeptides
encompassed the WH2 domain with either the N- or C-terminal
regions (Fig. 3G) the number of invadosomes and rosettes did not
significantly differ from that in cells expressing Myc-Spire-1
(n53 independent assays, each in triplicate). We thus
hypothesized that the adjacent domains could modulate the
properties of the WH2 domain. When extracts of HEK-293
cells expressing Myc-Spire-1, Myc-N-KIND or HA-Cter were
incubated with immobilized recombinant GST-WH2 (Fig. 4A,
left) or GST polypeptides (Fig. 4B), Spire-1 and the Cter but not
Fig. 1. Spire-1 expression is enhanced
in Src+ cells and is detected at the cell
periphery in actin-enriched
invadosome-like structures. (A) Spire1
transcripts were detected in total RNA and
quantified (histogram data are from four
independent experiments using two
different batches of RNA). The Arp3 gene
was used as reference; L, ladder (bp).
(B) Specificity of the anti-Spire-1 K19
(Santa Cruz) and the N-KIND-Spire-1
antibodies was controlled on whole-cell
extracts from 56104 to 56105 HEK-293
cells (black labels) and from HEK-293 cells
expressing a Myc-Spire-1 fusion protein
(red labels). The reliability of the detection
was assessed with an anti-Myc antibody
(9E10) whereas the GAPDH protein
served as loading control. L, ladder (kDa)
(C) Spire-1 protein expression was
quantified on 15 and 30 mg of 3T3-WT and
3T3-Src+ cell lysates and 30 mg of pre-
osteoblast-Src+ using anti-Spire-1 K19
antibodies. 30 mg of HEK-293 cell extract
served as control and GAPDH protein as
reference (histograms are derived from
five independent assays). L: ladder (kDa).
(D,E) In situ localization of Spire-1 in 3T3-
Src+ cells using N-KIND-Spire-1 antibodies
(green) and (E) co-stained with Phalloidin
to detect F-actin (red). White arrows show
invadosomes and rosettes (D);
arrowheads and arrows indicate individual
and clustered invadosomes, respectively
(E). Scale bars: 10 mm.
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the GST-WH2 (n59 independent assays), whereas no co-elution
was detected with GST alone (n53 independent assays). The
specificity of the interaction was validated using extracts from cells
expressing large amounts of the highly soluble HA-cofilin fusion
protein in the co-purification assay because we never detected the
protein in the GST-WH2 eluates (n53 independent assays)
(Fig. 4A, right). Of note, when the membranes were probed to
detect actin, we found that actin was efficiently captured by the
WH2 polypeptides, including when the latter interacted with the
HA-Cter domain. Thus, under these conditions, the intra-domain
interaction is unlikely to interfere with the actin binding properties.
Finally, in in vitro assays using recombinant polypeptides purified
from E. coli cells, GST-WH2 polypeptides were retained by His-
GST-Cter (Fig. 4C, black arrows) but not by His-GST-N-KIND
that was immobilized on nickel beads (Fig. 4C). Collectively, these
data suggest that Spire-1 can either adopt a conformation induced
by intramolecular interaction between the central WH2 and the C-
terminal domains of the protein or instead that Spire-1 homo-
dimerizes for optimal function.
Fig. 2. Myc-Spire-1 is selectively
recruited to invadosomes and is part of
a multi-molecular complex containing
mDia1, actin and Src kinase. (A) Triple
immunofluorescent labeling of 3T3-Src+
cells using N-KIND-Spire-1 (green), anti-
cortactin (red) antibodies and Phalloidin (F-
actin, blue). F-actin- and cortactin-enriched
invadosomes are also enriched with Spire-
1, see zoom inset (right). (B–D) Double
immunofluorescent labeling of 3T3-Src+
cells expressing Myc-Spire-1 using anti-
Myc c9E10 antibodies (green) and either
anti-cortactin, anti-pY418-Src or phalloidin
(red). Nuclei were additionally stained with
DAPI (blue) (B,C). Note the short and long
arrows marking individual and clustered
invadosomes, respectively. Framed areas
shown in the merge images are zoomed in
right panels and Pearson’s colocalization
coefficients are indicated below. (E) Myc-
Spire-1 was immunoprecipitated from 3T3-
Src+ cells using anti-Myc antibodies.
Whereas formin (mDia1), pY418-Src and
actin co-eluted with Myc-Spire-1, neither
the Arp2/3 complex nor its regulatory
component cortactin were found within the
complex. GAPDH served as a negative
control. P, pellet; L, lysate; unB, unbound;
B, bound. (F) 3T3-Src+ cells were co-
stained with N-KIND-Spire-1 (green) and
anti-mDia1 antibodies (red) and with
Phalloidin (blue). Framed area shown in the
merge image is zoomed in the bottom
panel and Pearson’s coefficients quantify
signal colocalization. Scale bars: 10 mm.
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Rab3A interacts with the Spire-1 C-terminal region
Regulated exocytosis is a prominent feature of invadosome
activity and RabGTPases are the major regulators of polarized
trafficking of vesicles to recipient membranes. Interestingly, the
homology of the Spire box and the rabphilin-3A a-helix suggests
a contribution of this domain in the association of Spire with a
small RabGTPase. Within the large RabGTPase family, many are
involved in cancer progression, both as inhibitory and promoting
factors (Ho et al., 2012). Although Rab3A plays a major role in
regulating exocytosis in a number of neuronal and endocrine cells
(Baldini et al., 1995; Leenders et al., 2001; Pavlos et al., 2010), as
well as in sperm (Bustos et al., 2012), it also has a role in cancer
cells: Rab3A is upregulated in insulinoma but not in normal islets
of pancreatic tissue (Lankat-Buttgereit et al., 1994). Rab3A
protein is overexpressed in aggressive breast stem-like tumor
cells and in epithelial breast cancer cells in response to Heregulin
(Vadlamudi et al., 2000) as well as in myofibroblasts (Ina et al.,
2005). Interestingly, we found a modest increase in Rab3A protein
Fig. 3. The Spire-1 WH2
domain drives Spire-1 to
invadosomes. 3T3-Src+ cells
expressing Myc-Spire-1 (A) or
truncated Spire-1 fusion proteins
(B–F) were labeled with anti-Myc
antibodies (green) and with
phalloidin to detect F-actin (red).
Note the large rosettes indicated
by white arrows (E,F). Percentage
of cells for which F-actin-labeled
invadosomes are positive for
Myc-tagged Spire-1 polypeptides
of interest are shown on the right
(200,n.300 cells). Scale bars:
10 mm. (G) Histograms show the
number of rings or rosettes (red),
or individual invadosomes (gray)
for 100 cells; average numbers
from triplicates are indicated.
Statistical analysis was performed
using the Student’s t-test;
*P,0.05. Note that the presence
of WH2 domain was required for
Spire-1 localization at
invadosomes and that addition of
the N- or C-terminal domains
regulated the enhanced effect of
WH2 domain on invadosome and
ring numbers.
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expression of about 1.6- and 2.8-fold in Src+ when compared with
3T3-WT cells (supplementary material Fig. S4A). Moreover, a pool
of endogenous Rab3A accumulated at invadosomes and rosettes in
dot-like vesicles in 3T3-Src+ cells (Fig. 5A; supplementary material
Fig. S4B, see the higher magnification of insets 1 and 2 in right
panels). When these cells co-expressed Myc-Spire-1 and GFP-Rab
proteins, a significant overlap was seen between Myc-Spire-1 and
GFP-Rab3A (Fig. 5B and Pearson’s coefficients) but not between
Myc-Spire-1 and the early endosomal marker GFP-Rab5A
(Fig. 5C). The coincident Rab3A and Myc-Spire-1 signals marked
individual and clustered invadosomes (Fig. 5B). Because a Spire-1
and Rab3A GTPase interaction has not yet been reported, we next
checked whether both proteins could co-purify under pull-down
assay conditions. When Myc-Spire-1 was immunoprecipitated from
Src+ cells expressing Myc-Spire-1 with either GFP-Rab3A or GFP-
Rab5A, only GFP-Rab3A was pulled down as a Spire-1 partner
(Fig. 5D, n55 independent experiments). This binding was
confirmed in vitro using immobilized recombinant GST-Rab3A
and extracts from HEK-293 cells expressing several truncated Spire-
1 constructs (Fig. 5E): Myc-Spire-1 indeed bound to GST-Rab3A as
did the Cter domain, in contrast to the N-KIND domain, whereas
none of the recombinant proteins or polypeptides co-eluted with
GST alone (data not shown). Since p150-Spire-1 was reported to
colocalize with Rab11 and to function along the exocytic pathway
(Kerkhoff et al., 2001; Schuh, 2011) and since a subset of GTPases
including Rab8A were recently implicated in the release of MTP1-
MMP at the plasma membrane in primary macrophages (Wiesner
et al., 2013), we checked whether any of these could be recruited at
invadosomes. By analysing the distribution of GFP-Rab7A, GFP-
Rab8A or GFP-Rab11A expressed in 3T3-Src+ cells, we often
observed GFP-Rab7A and GFP-Rab11A in the vicinity
of invadosomes as vesicles, but only GFP-Rab8A was
detected partially overlapping with F-actin-marked invadosomes
(supplementary material Fig. S5C, see also the magnified area as
insets at the bottom). When cells co-expressed GFP-Rab8A and
Myc-Spire-1, many coincident dot-like signals were observed
(supplementary material Fig. S6A, white arrow), including at the
edges of invadosomes and rosettes well labeled with Phalloidin
(supplementary material Fig. S6A, white arrowheads) possibly
suggesting a wider interplay between Rab proteins and Spire-1. Of
note, overexpression of Rab7A was also accompanied by a
significant reduction in the number of invadosomes (data not
shown). Collectively, our data support a specific partnership
between Spire-1 and Rab3A that contributes to invadosomes and
might function in concert with other Rab proteins, notably Rab8A.
The level of Spire-1 expression modulates degradation of the
extracellular matrix
The results suggesting a partnership between Spire-1 and Rab3A
prompted us to verify whether Spire-1 could modulate
invadosome-mediated functions. Although we could not obtain
a reliable downregulation of Spire-1 in 3T3-Src+ cells despite
using several siRNA sequences, we succeeded in decreasing the
level of expression to 45% of that in control cells when using
human breast cancer MDA-MB-231 cells. This is a common cell
line model used to study invadosome-mediated matrix
degradation, in particular when MMPs are overexpressed
(Artym et al., 2006) (Fig. 6A). Therefore we assayed whether
decreasing Spire-1 expression could impair the ability of
MDA-MB-231 cells to degrade matrix by interfering with
proper delivery of proteases at invadosomes. To this end, cells
were silenced for Spire-1 expression (siSpire-1) while transfected
to express the fusion MT1-MMPmCherry protein (see Materials
and Methods). As a positive control, we also silenced expression of
Fig. 4. The Myc-Spire-1 C-terminal
domain binds to the WH2 domain.
(A) Western blot showing that cell extracts
containing Myc-Spire-1 and HA-Cter but not
Myc-N-KIND were captured by immobilized
GST-WH2 polypeptides. The specificity of
the capture was controlled by (1) using HA-
cofilin-containing cell extracts (right panel)
and (2) conducting the same assays on
immobilized GST (B). Actin was detected in
all the GST-WH2 eluates suggesting that the
interaction between the Spire-1 domains
does not regulate the actin-binding
properties to actin of the WH2 motifs
(A, bottom panel). (C) Bacterially expressed
His-GST-Cter and N-KIND domains were
purified and immobilized on nickel beads
(i-beads) as assessed with anti-His
antibodies and further capture of the GST-
WH2 domain was assessed using anti-GST
antibodies. P, pellet; L, lysate; unB,
unbound; B, bound.
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cortactin (siCort, 89% of signal extinction) since it was reported to
impair MDA-MB-231 matrix proteolytic activity (Artym et al.,
2006) (supplementary material Fig. S5B). Gelatin degradation was
subsequently measured after 6 hours of contact with cells by
quantifying the loss of fluorescent signal associated with
cells. When compared with cells transfected with irrelevant
siRNA oligonucleotides (Ct), MT1-MMP-mCherry-expressing
cells silenced for cortactin or for Spire-1 exhibited a decrease
of about 60% and 36% in their capacity to degrade gelatin,
respectively (Fig. 6C,D). Conversely, we tested whether increasing
the level of Spire-1 expression could enhance invadosome
proteolytic function in 3T3-Src+ cells. The gelatin-degradation
assay was kept identical except the cells were transfected
to express Myc-Spire-1. Although F-actin and Myc-Spire-1
incorporated at invadosomes and at some cell protrusions, these
domains topologically correlated with area of digested gelatin
(Fig. 7A, white arrows). Sampling cells that either weakly or
strongly overexpressed Myc-Spire-1 by measuring pixel intensity
per cell area (high and low, respectively, Fig. 7B,C) highlighted a
significant correlation between the level of Myc-Spire-1
expression and cell proteolytic activity (n.60 cells). The number
of cells associated with substrate digestion was only increased
significantly in 3T3-Src+ cells expressing high level of Myc-Spire-
1 when compared with low or undectable levels of Spire-1
expression in the same field of observation (Fig. 7B,C,F,G). As
additional controls, 3T3-Src+ cells expressing Myc-Spire-1 that
were exposed to the potent broad spectrum metalloprotease
inhibitor batimastat (BB94, 10 mM) during the assay were unable
to degrade the matrix (Fig. 7D,G) although they exhibited an intact
actin cytoskeleton and invadosomes. By contrast, overexpression
of MT1-MMP-mCherry strongly promoted matrix degradation
activity (Fig. 7E,G). Collectively, our functional assays suggest
that Spire-1 is involved in promoting metalloprotease-dependent
proteolytic activity on the matrix at active invadosomes.
Overexpression of Myc-Spire-1 associates with an increase in cell-
invasion properties
Leukocytes and cancer cells elicit physiological and dysregulated
properties that support their ability to invade not only the ECM
but also cellular monolayers, in particular at the vasculature level.
Because endothelial cells line the blood vessel walls, we next
investigated whether Spire-1 expression could correlate with cell
invasiveness. To this end, we took advantage of the human brain
endothelial capillary cell line (hCMEC/D3) that organizes as a
Fig. 5. Rab3A colocalizes with Spire-1-
positive invadosomes and interacts
with the C-terminal but not the N-
terminal domain of Spire-1. (A) Double
immunofluorescent labeling of 3T3-Src+
cells with anti-Rab3A antibodies (green)
and Phalloidin (F-actin, red). Framed
areas 1 and 2 shown in the merge image
are zoomed in right panels 1 and 2. Note
that Rab3A-positive vesicles converge at
the F-actin core of invadosomes. 3T3-
Src+ cells co-expressing Myc-Spire-1 and
GFP-Rab3A (B) or GFP-Rab5A (C) were
stained with anti-Myc antibodies (red).
Framed areas in the merge image are
used to quantify colocalization (B) using
Pearson’s coefficient. Scale bars: 10 mm.
(D) Myc-Spire-1 was immunoprecipitated
from 3T3-Src+ cells co-transfected with
Myc-Spire-1 and either GFP-Rab3A or
GFP-Rab5A. Rab3A (left) but not Rab5A
(right) co-eluted with Myc-Spire-1.
GAPDH served as internal control protein
loading. Molecular mass is indicated in
kDa. (E) Recombinant GST-RAb3A was
immobilized on beads and incubated with
HEK-293 cell extracts expressing Myc-
Spire-1, Myc-N-KIND or HA-Cter
domains. Western blot shows that full-
length Spire-1 and the HA-Cter but not
the N-KIND-domain interact with Rab3A.
L, lysate; unB, unbound; B, bound.
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functional endothelial barrier (Weksler et al., 2005). We used the
impedance-based xCELLigence RTCA device that allows real-time
measurement of the changes in electrical resistance of a cell
monolayer adhering on top of gold electrodes placed at the bottom
surface of microplates. Impedance values are further translated into
cell indexes (CI) that increase with culturing time to reach a
characteristic plateau for each barrier-forming cell type. A CI of
about 7 corresponds to a tight functional cellular barrier routinely
obtained with hCMEC/D3 after 40 hours of culture under our
conditions. Barrier integrity was assessed by adding hyper-osmolar
mannitol that instantaneously destabilizes the tight junctions
between adjacent cells (Luissint et al., 2012) and induced a rapid
and substained drop in CI (Fig. 8A, top graph). When single-cell
suspensions were added to the endothelial layer, CIs dropped
according to the extent of disturbance and the duration of barrier
integrity. 3T3-WT fibroblasts (pink line) that do not form
invadosomes and do not efficiently invade monolayers had a
moderate effect on the endothelium cell index, in contrast to
invasive 3T3-Src+ cells (dark green line) (Fig. 8A, bottom panel).
Of note, drops in the CI were more pronounced for 3T3-Src+ cells
overexpressing either Myc-WH2 (light blue) or Myc-Spire-1 (dark
blue) when compared with cells expressing a Myc-irrelevant
polypeptide (light green line), thus indicating a stronger impact on
the barrier stability of hCMEC/D3. The histograms showed that the
disturbance of the monolayer integrity progressed over time when
deposition at 10 and 20 hours was compared (data are
representative of one representative experiment performed in
quadruplicate out of three independent assays, Fig. 8B, top
histogram). Drops in the CI are given by the slopes of the curves
and they correlated with the extent of CI changes because cells
expressing Myc-WH2 and Myc-Spire-1 displayed the highest
values (Fig. 8B, bottom histogram). Finally, monitoring of cells
overexpressing Myc-Spire-1 or GFP-Spire-1 during the trans-
migration process across VE-Cadherin-labeled monolayers
confirmed that Spire-1 accumulated in dot-like spots that were
preferentially located in the membrane expansions (Fig. 8C) that
colocalized with actin-enriched sites (Fig. 8D, see higher
magnifications in insets). Therefore, in our in vitro model, the
rate and amplitude of the endothelium barrier destabilization are
modulated by Spire-1 in invadosome-forming cells.
DISCUSSION
The aggressiveness of cancer cells is characterized by their ability
to invade across tissue boundaries, by breaching and degradation
of ECM, navigation within the stroma and crossing the
vasculature (Parekh et al., 2011). A gain of invasive activity
can reflect a vast panoply of structural and regulatory changes
depending on cell and tissue types, but they most often converge
on an increase in the motile properties of cells. Such an increase
is commonly associated with the acquisition of specialized
mechano-sensitive structures that are actin-rich, finger-like
cellular protrusions or invadosomes (Murphy and Courtneidge,
2011). In addition to driving motile behavior, these appendages
are also sites towards which proteolytic enzymes traffic and are
then released to degrade ECM locally (Linder et al., 2011).
A recent comprehensive proteomic-based analysis applied to
‘invadosome-like’ macrophages has unveiled the complexity
of their architecture. Strikingly, among the 203 components
identified, 170 are new structural and regulatory members largely
composed of cytoskeleton proteins, GTP-binding and GTPase
factors (Cervero et al., 2012). Invadosome scaffolding relies on
actin nucleation, with a tight cooperation between the Arp2/3
Fig. 6. Silencing of human Spire-1 in MDA-MB-
231 cells reduces gelatin matrix degradation.
(A) MT1-MMP-mCherry (MT1-MMP-mC)
overexpressing MDA-MB-231 cells were associated
with a much more pronounced gelatin-degradation
area when compared with cells that did not express
MTP1-MMP-mC. Cells were stained with anti-
cortactin antibodies (B) Western blots show the
levels of silencing of Spire-1 (siSpire-1) and
Cortactin (siCort) for 105 MDA-MB-231 cells
expressing MT1-MMP-mC. Cells (Ct) treated with
AllStars Negative Control siRNA (Qiagen) were
used as controls whereas tubulin-b and GAPDH
were used as internal loading controls. Molecular
mass is shown in kDa. (C,D) 105 cells of the
silenced cell populations were cultured on a FITC-
gelatin layer for 6 hours. Areas of cells and
fluorescence loss in MT1-MMPmC-expressing cells
were quantified using ImageJ software.
(C) Histograms represent the ratio of area of gelatin
degradation to the cell area for control (Ct), Spire-1
(siSpire-1)- and cortactin (siCort)-silenced cells (two
independent experiments, for each n540 cells
expressing the MT1-MMP-mC protein). Statistical
analysis was performed using the Student’s t-test,
*P,0.05. (D) Ct and Spire-1-silenced cells were
stained with anti-cortactin antibodies and cortactin-
silenced cells were labeled with Phalloidin. Areas of
gelatin matrix degradation appeared as dark spots:
note the decrease of digested gelatin area for Spire-
1- and cortactin-silenced cells when compared with
Ct cells. Scale bars: 10 mm.
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Fig. 7. Overexpression of Spire-1 in 3T3 Src+ cells increases gelatin matrix degradation. (A–E) 20 hours post transfection with the Myc-Spire-1 (A–D) or
MT1-MMPmC (E) encoding plasmids, 66104 3T3-Src+ cells were deposited on top of a thin layer of a FITC-gelatin and cultured for 6 hours (A–C) or in the
presence of 10 mM of the MMP inhibitor BB94 (D). Cells were stained with anti-Myc antibodies and fluorescent Phalloidin (A–D). White arrows indicate Spire-1
and F-actin-positive invadosomes and the corresponding matrix degraded spots (A). Selected frames of cells expressing high (B) or low (C) levels of Myc-Spire-
1 juxtaposed with cells expressing no detectable protein are shown with the corresponding gelatin-degradation area. Note the absence of digested gelatin area
for cells treated with BB94 (D) that strikingly contrasts with the large loss of gelatin area seen for cells overexpressing MT1-MMPmC (E). Scale bars: 10 mm.
(F,G) Histograms show the percentage of cells (n550) that associated with matrix digested area (F) and the index of matrix degradation (G) for different
categories of cells including non-transfected cells (NT), mock (mock T) and Myc-Spire-1 (hi, high; lo, low) transfected cells. Statistical analyses were performed
using the Student’s t-test, *P,0.05; NS, not significant.
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actin-nucleating complex and the class of formins. For instance, a
sixfold increase in FRL1 formin expression accompanies
differentiation of human peripheral blood monocytes in
macrophages (PBMCs) with preferential protein localization at
the actin core of podosomes (Mersich et al., 2010). Full
competence of invadosome proteolytic activities was also
shown to depend on the formins present in cancer cells
(Liza´rraga et al., 2009). The present study enlarges the
contribution of actin nucleators to invadosome biology with the
identification of Spire-1 as the third nucleator type to add to
the list. First, we found that Spire-1 was expressed and recruited
to individual and clustered invadosomes in Src-transformed cells.
The participation of Spire-1 to a molecular complex containing
the formin mDia1, but not Arp2/3, together with the presence of
formin in a cap layering the actin-Arp2/3 core (Mersich et al.,
2010) support a selective interplay between different actin
nucleators to the multipartite architecture of invadosomes. Spire
has already been shown to function in cooperation with either the
Arp2/3 complex and more frequently with formins to drive
vesicular movement during the endocytic and exocytic pathways
(Morel et al., 2009; Schuh, 2011). Interestingly, our study seems to
indicate that the mDia1-Spire1 partnership occurs at invadosomes
without ruling out the possibilities that other members of the broad
formin family also act as partners of Spire-1 along the exocytic
pathway. Regulatory interactions between the FH2 domain of the
Cappuccino family formin (or the formin 2, Fmn2) and the Spire
KIND domain have been identified in vitro and in vivo (Quinlan
et al., 2007). Because we identified Spire-1and mDia-1 within the
Fig. 8. Overexpression of Myc-Spire-1
associates with an increase in the
invasive properties of 3T3-Src+ cells.
(A) Graphs showing cell index (CI, arbitrary
units, a.u.) for hCMEC/D3 cells grown to
confluency using the xCELLigence RTCA
device. When a CI of about 7 was
stabilized, change in culture medium or
addition of mannitol, which disrupts cell
tight junctions (arrows), led to slight or
drastic changes in impedance,
respectively (top graph). Addition of 3T3-
WT (pink), 3T3-Src+ (dark green), 3T3-
Src+ expressing Myc-Spire-1 (dark blue),
3T3-Src+ expressing Spire-1-WH2 domain
(light blue) and 3T3-Src+ expressing
irrelevant Myc fusion protein (light green)
disturbs barrier function to variable extents
over time (Fig. 8A, bottom graphs). (B) The
histograms recapitulate the disturbance
caused on monolayer integrity by addition
of cell populations at 10 and 20 hours after
cell deposition (top histogram) and the rate
in CI decrease (bottom histogram). Data
are representative of one representative
experiment performed in quadruplicates
out of three independent assays).
***P,0.01; ****P,0.001. (C,D) Cells
overexpressing Myc-Spire-1 (C) or both
GFP-Spire-1 and mCherry-actin (mC-
actin) (D) are trans-migrating across an
endothelial monolayer stained (D) using
anti-VE-cadherin antibodies to visualize
tight junctions between adjacent cells.
Confocal z planes are indicated; DIC (top
panel in C) and fluorescent (bottom panel
in C, and D) images show Myc-Spire-1 and
GFP-Spire-1 at the membrane extensions
(white arrows, C). Note that the peripheral
GFP-Spire-1 dots colocalize with mC-actin
(D), zoomed images of merge framed
areas 1 and 2, bottom panels). Scale bars:
10 mm.
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same complex in Src+ cells and probably also at the invadosomes,
it will be of further interest to decipher whether the formin also
activates Spire-1 nucleation activity in these sites.
Following the discovery of Spire-1 at invadosome sites, we next
assessed whether Spire-1 contributes to invadosome functions by
analysing the impact of Spire expression level on two of their main
properties: ECM degradation and breach of the tissue or cellular
barrier. First, using gelatin-degradation assays, we showed a moderate
decrease of cell proteolytic activity when Spire-1 expression was
lowered by RNA interference and a reciprocal increase when cells
overexpressed Spire-1. Second, we monitored in real time the effect of
overexpression of Spire-1 on the ability of cells to invade endothelial
barriers and found that overexpressing Spire-1 speeded up and
increased the extent of endothelial monolayer invasion. Of note,
because we relied on cells with transfection rates varying between
40% and 50%, our data might under-report the real impact of Spire-1
on the invasiveness of Src+ cells towards endothelia.
These functional data unveil a contribution of Spire-1 during
ECM lysis and vessel breaching. In line with this, we detected
Spire-1 localized as dots closely juxtaposed to F-actin in membrane
expansions of cells crossing endothelia. In addition, Spire-1 and the
Drosophila p150 Spire were proposed to act at the secretory
pathway controlling Golgi vesicular trafficking in 3T3-WT
fibroblasts that do not form invadosomes, through a possible
connection with Rab11 with which exogenous p150-Spire
colocalizes (Kerkhoff et al., 2001; Schuh, 2011). Moreover, a
close spatial relationship between cancer cell invadopodia and the
Golgi has been already reported (Buxione et al., 2004). In support of
the involvement of Spire-1 in the secretion of lytic enzymes at
invadosome sites, we found that modulation of Spire-1 expression
affects their digestive potency. Pro-invasive activities of MMPs
require their targeting to invadosomes, a process that is expected to
be driven by a combinatory set of Rab GTPases and effectors that
still need to be characterized in detail. Interestingly, Rab27A, which
is defined as a functional partner of Rab3A, has been associated
with the invasive and metastatic potential of breast cancer cells,
because it promotes the expression of several proteases involved in
breaching of the ECM (Tedone et al., 1997). Rab3A has also been
directly involved in regulated exocytosis in several cell types,
including those switching to aggressive tumor cell behavior. Our
study uncovers a novel partnership between Rab3A and Spire-1 at
the invadosome sites and this finding fits with the concomitant
upregulation of both proteins in Src+ cells. The selective implication
of the Spire-1 C-terminal domain in the interaction with Rab3A
might explain why the Spire-1 N-KIND domain, when expressed
alone does not follow a typical dot-like distribution (Fig. 3;
supplementary material Fig. S3). Collectively, these results are
consistent with a role for Spire-1 in vesicular trafficking of lytic
products through the secretory or exocytic pathway. If the Rab3 and
Spire-1 partnership promotes the polarized vesicular traffic of
MMPs to invadosomes, other Rab proteins, in particular Rab8,
which are known to regulate MMP traffic and exocytosis (Bravo-
Cordero et al., 2007) are likely to be part of the process as well.
Remarkably, we observed a strong association between Rab8A and
Spire-1 vesicles in the cytoplasm of Src+ fibroblasts, whereas at the
invadosome sites, the membrane-associated MT-MMP1 was clearly
seen at the membranous edges and Myc-Spire-1 remained
coincident with the F-actin-enriched invadosomes. These
observations suggest that Spire-1 might indeed be important for
invadosome structure and function (supplementary material Fig.
S6B). Future work should aim to assess whether and how Spire-1
contributes to the scaffolding of invadosomes.
In conclusion, our results newly support a cooperation of Spire-
1 with other components to actin nucleation and vesicular traffic
at the invadosome sites in cancer and transformed cells. In
addition to supplying invadosomes with proteolytic products,
exocytosis of Spire-1-positive vesicles could also provide
membrane material to fold these growing protrusive devices
and it will be of interest to assess the contribution of Spire-1 to
matrix or tissue invasion under 3D conditions. Future studies
should aim to decipher the interplay between the different classes
of actin nucleator. This would lead to an understanding of the
control of vesicular trafficking and docking of enzymes at
invadosomes or protrusive invasive pseudopods whose activities
accompany numerous physiological and pathophysiological
processes, most importantly cancer metastasis.
MATERIALS AND METHODS
Cell culture
Culture media and reagents were purchased from Gibco, Life Technologies
(Saint Aubin, France) unless specified. Human embryonic kidney cells
(HEK-293) and MDA-MB-231 breast adenocarcinoma cells, mouse
embryonic fibroblasts (NIH3T3) WT and stably expressing active Src
(Src+) cells and pre-osteoclasts stably expressing active Src were grown in
Dulbecco’s minimum essential medium (DMEM) supplemented with
glutamax, 10% heat-inactivated fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 mg/ml) and 10 mM HEPES. Human brain endothelial
cells (HCMEC/D3) were grown in EBM-2 medium supplemented as
described (Luissint et al., 2012; Lonza, Verbiers, Belgium). Cells were
cultured at 37 C˚ under 95% O2 and 5% CO2.
RT-PCR to detect Spire1 transcripts in different cell lines
RNA was extracted using the RNeasy Mini Kit (Qiagen, Courtaboeuf,
France) according to the supplier’s instructions. For cDNA synthesis
2.5 mg of total RNA were retro-transcribed using the SuperScript kit
(Invitrogen Life Technologies). For control reactions, 2.5 mg of RNA
was treated without reverse transcriptase. PCR was performed with NEB
Taq Polymerase in a 25 ml final volume containing 1/10th cDNA volume,
0.2 mM of primers and 200 mM of DNTPs. The integrity of cDNA was
checked by amplification of the housekeeping gene Arp3, and Spire1
transcripts were detected with specific primers targeting mouse Spire1
but not Spire2 genes (all primers are listed in supplementary material
Table S1). Integrity of the PCR products was controlled by nucleotide
sequencing before further analysis.
Western blot analysis of Spire-1 and Rab3A
Whole-cell extracts ranging from 56104 to 56105 cells or protein lysates
(15–50 mg) were analyzed by SDS-PAGE and western blotting.
Nitrocellulose membranes were probed with appropriate primary
(supplementary material Table S2) and secondary HRP-coupled
antibodies (Pierce Fisher Scientific, Illkirch, France). Chemiluminescent
signals were scanned and quantified using ImageJ software (W. Rasband,
NIH, Bethesda, MD) and normalized to GAPDH signals.
Cloning procedures
The plasmid pCDNA3-Myc Spire1 was used as a template to amplify the
different regions of interest: full length Spire-1, the region encompassing
the four WH2 domains (268–480aa) and the Cter (556–756aa); WH2-
Cter (268–756aa), N-KIND (1–230aa) and N-KIND-WH2 (1–460aa)
domains were amplified with appropriate primers. Fragments were
further cloned in pEGFP-C3 (Spire-1) or in pCS2-Myc (domains)
plasmids. The C-terminal domain was also cloned in pCS2-HA plasmid.
For affinity pull-down assay, a GST-WH2 recombinant polypeptide was
cloned in the pGex6-p3 vector. For interaction assays, N-KIND (1–
230aa) and C-terminal (389–756aa) domains were amplified and cloned
in the pET2817 plasmid modified to express a His-GST tag in N-terminal
part of the fusion protein (pET2817-hGST, from S. Bellais, Institut
Cochin, Paris). The PCR fragments were inserted in the PET2817-hGST
plasmid using the In-Fusion HD cloning kit (Takara Bio/Clontech)
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following manufacturer’s instructions. Primers also encompassed NcoI
and BamHI sites for positive clone screening. Corresponding primers are
listed in supplementary material Table S1.
Cell transfection
Transfections were performed with the JetPei reagent (Polyplus, Illkirch,
France) for HEK-293 cells, with Lipofectamine LTX (Invitrogen Life
Technologies) for MDA-MB-231 and pre-osteoclast-Src+ cells and with the
NeonH Transfection System (Invitrogen Life Technologies) for 3T3-Src+
cells (1200 V, 20 ms, three pulses). In all experiments, cells were cultivated
for ,24 hours in complete medium before further analysis. For silencing
experiments, MDA-MB-231 cells were treated with small interfering RNAs
targeting Spire1 (pool of three siRNA AMBION s32366, s32367 and
s32368, 30 nM each) or with 100 nM of siRNA targeting cortactin
(Sauvonnet et al., 2005) (Eurogenetc) or with 50 nM of AllStars Negative
Control siRNA (Qiagen, Courtaboeuf, France). Two rounds of transfection
were performed using the transfection agent LipofectamineH RNAiMAXTM
(Invitrogen, Lifetechnologies) 24 hours and 72 hours after passaging,
respectively. At 24 hours post silencing transfection, cells were
transfected using Lipofectamine LTX (Invitrogen Life Technologies) to
ectopically express a MT1-MMP-mCherry fusion protein.
Immunostaining, microscopy and image analysis
Cells were fixed in 4% paraformaldehyde (20 minutes, 23 C˚),
permeabilized in 0.5% (v/v) Triton X-100 (TX-100, 5 minutes, 23 C˚)
and incubated in PBS with 2% (w/v) BSA (20 minutes, 23 C˚) before
adding the appropriate primary and Alexa-Fluor-coupled secondary
antibodies (supplementary material Table S2) or Alexa Fluor Phalloidin
(Invitrogen Life Technologies). In some assays, nuclei were stained with
49,6-diamidino-2-phenylindole (DAPI). Cells were observed under a
confocal microscope (Eclipse Ti Nikon). Image stacks were acquired
with a 14-bit Cool SNAP HQ camera (Roper Scientific, Lisses, France)
under Metamorph software (Universal Imaging Corporation) and further
processed with ImageJ and Adobe R Adobe Photoshop software.
Maximal projections are shown in Figures.
Immunopurification of the Spire-1 complex
106 3T3-Src+ cells ectopically expressing Myc-Spire-1 were solubilized in
lysis buffer A and centrifuged (20,000 g, 20 minutes, 4 C˚). Supernatants
were incubated with anti-Myc agarose beads (Sigma-Aldrich, St Quentin
Fallaviers, France) (2 hours, 4 C˚) before extensive washing. Bound proteins
were eluted in 50 ml of SDS sample buffer, DTT (25 mM) was added and
samples were subjected to SDS-PAGE. Proteins were transferred to
nitrocellulose membranes before western blotting with appropriate
antibodies (supplementary material Table S2). GAPDH was used as a
control of specificity. Similar protocols were applied to investigate Myc-
Spire-1 partnerships with GFP-Rab3A starting with 3T3-Src+ cells co-
transfected with Myc-Spire-1 and GFP-Rab3A or GFP-Rab5A.
In vitro interaction assays
Recombinant GST-WH2 and GST proteins were produced in
BL21(DE3)pLysS E. coli strain (2 hours, 37 C˚ 0.1 mM isopropyl
b-D-1-thiogalactopyranoside (IPTG), Euromedex, Souffelweyrsheim,
France). Bacteria were solubilized in buffer B supplemented with 0.5%
TX-100 (30 minutes, 4 C˚). After centrifugation (43,000 g, 10 minutes, 4 C˚),
supernatants were incubated with glutathione-Sepharose C4B beads (Ge
Healthcare, Strasbourg, France) (2 hours, 4 C˚). Beads were washed with
buffer B supplemented with 0.01% TX-100 and subsequently equilibrated in
buffer C. HEK-293 cells expressing Myc-Spire-1, Myc-KIND or HA-C-
terminal fusion polypeptides were solubilized in buffer C supplemented with
0.1% TX-100 (20 minutes, 4 C˚) and lysates were centrifuged (20,000 g,
20 minutes, 4 C˚). Half of the supernatant was incubated with immobilized
GST-WH2 and the other half with immobilized GST (2 hours, 4 C˚). Beads
were spun down (1000 g, 5 minutes, 4 C˚) and unbound products were
eliminated with buffer C containing 0.01% TX-100. Bound proteins were
eluted in 40 ml of SDS-sample buffer containing DTT and analyzed by SDS-
PAGE and western blot using appropriate antibodies (supplementary
material Table S2). Recombinant GST-Rab3A proteins were produced in
the Rosetta BL21 E. coli strain (5 hours, 37 C˚, 0.5 mM IPTG). Bacteria
were resuspended in buffer D and treated as described above with the
addition of 1 mM of GTP prior and during the interaction assay. HEK-293
cells were collected in buffer E, ruptured with liquid nitrogen and incubated
on ice (20 minutes). After centrifugation, lysates were incubated with
immobilized GST or GST-Rab3A (2 hours, 4 C˚) unbound proteins were
eliminated whereas bound proteins were analyzed by SDS-PAGE and
western blotting (supplementary material Table S2). In vitro assays were
conducted with 5 mg of recombinant protein immobilized on nickel beads
and further incubated with 5 mg of pre-dialyzed GST-WH2 domains in a
final volume of 100 ml of buffer B supplemented with 0.02% of TX-100
(2 hours, 4 C˚). Following elimination of unbound material, eluates were
recovered in SDS-PAGE sample buffer containing DTT and further
analyzed by SDS-PAGE and western blotting.
Gelatin-degradation assay
Gelatin-degradation assays were performed as described previously (Artym
et al., 2006). 6 104 3T3-Src+ cells either mock transfected or transfected
with either Myc-Spire-1 or MT1-MMP-mCherry plasmids were plated
20 hours post transfection on the gelatin layer covering a 18 mm glass
coverlisp and cultured in DMEM containing 0.2% FBS (6 hours, 37 C˚)
before immunostaining. In some experiments, 3T3-Src+ cells expressing
Myc-Spire-1 were exposed to the metalloprotease inhibitor, batimastat
(BB94, 10 mM) over the assay period. Matrix degradation was assessed by
quantifying (1) the number of cells associated with degradation and (2) the
local area of loss of fluorescence with respect to cells (,50 cells for each
transgene expression and/or treatment; two independent experiments). A
similar protocol was applied to silenced MDA-MB-231 cells (105 on gelatin-
coated coverslips). The extent of matrix degradation was assessed by
quantifying fluorescence loss with respect to cell area (,40 MT1-MMP-
mCherry-expressing cells for each siRNA treatment; two independent
experiments). Merged image stacks were analyzed using ImageJ software
and statistical analyses were performed using the Student’s t-test.
Transmigration assays on endothelial barrier
To monitor cell invasion through a monolayer of HCMEC/D3 cells, we used
the impedance-based xCELLigence Real-Time Cell Analysis detection
technology (Roche Applied Science). Invasion experiments were carried out
in 96-well microplates in a humidified incubator at 37 C˚ and 5% CO2 and
data were recorded with the RTCA software (versus 1.2.1). First,
xCELLigence E-plates 96 (Roche) were coated with 0.1% gelatin (1 hour,
37 C˚) and filled with medium to measure background impedance in the
absence of cells. Then, 1.56104 HCMEC/D3 cells were seeded per well and
grown until they formed a monolayer and reached a plateau of maximal cell
index values. Medium was changed after 48 hours of culture. When the
plateau was stabilized, single-cell suspensions of 1.56104 3T3-WT or -Src+
cells transfected 20 hours before with plasmids encoding irrelevant Myc-
polypeptide, Myc-Spire-1 or Myc-Spire-1 domains were deposited on top of
the monolayer in 10% FBS DMEM medium. Monolayer disturbance during
cell invasion was recorded over a period of 30 hours (every 5 minutes for
the first 2 hours, every 15 minutes for next 2 hours and every 30 minutes for
the remaining period). To catch the trans-migration process, the assay
was performed with ten times more 3T3-Src+ cells expressing both GFP-
Spire-1 and mCherry-actin and cells were fixed for immunofluorescence
labeling (VE-Cadherin) after 4 hours of contact.
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Fig. S1. Western blot on whole cell extracts from 5x104 to 5x105 HEK-293 cells transfected with AllStars Negative Control 
siRNA (Qiagen) (Ct) or with siSpire-1 oligonucleotides (siSpire-1). The membrane was probed with the K19 anti-Spire-1 
antibodies and anti-GAPDH antibodies. Note that K19 but not the GAPDH signal was significantly reduced in silenced cells. 
L: ladder (kDa).
Fig. S2. (A) Co-localization of endogenous Spire-1 and exogenous myc-Spire-1. 3T3-Src+ cells were stained with N-KIND-
Spire-1 (green) and anti-myc (red) antibodies. Arrows and arrowheads show individual and clustered invadosomes, 
respectively. Framed area shown in the merge image is zoomed in right panel focusing on several invadosomes and a rosette. 
(B) Triple fluorescent labeling of 3T3-Src+ cells using N-KIND-Spire-1 (green) and Cortactin (red) antibodies and phalloidin 
(F-actin, blue); note the marked co-enrichment of the three proteins at invadosomes. (C,D) Transiently expressed GFP-Spire-1 
(green) accumulates at F-actin enriched invadosomes in 3T3-Src+ (C) and in pre-Ost-Src+ (D) cells, short and long white 
arrows mark invadosomes and rosettes respectively (D). (E) Triple fluorescent labeling of 3T3-Src+ cells with N-KIND-Spire-1 
(green) and anti-mDia1 (red) antibodies and with phalloidin to detect F-actin (blue); note that endogenous mDia1 and Spire-1 
signals overlap only at invadosomes/rings sites as specified by the Pearson’ co-localization coefficient. Scale bar: 10 μm.
Fig. S3. The Spire-1 WH2 domain drive Spire-1 to invadosomes. (A) Schematic representation of Spire-1 truncates in fusion 
with either myc (red boxes) or HA (blue boxes) tags engineered for mammalian expression. (B-E) 3T3-Src+ cells transiently 
expressing Spire-1 truncates in fusion with either myc (B-D) or HA (E) tags were labeled with anti-myc or anti-HA antibodies 
(green) and with phalloidin to detect F-actin (red). Note 27 the diffuse cytoplasmic staining together with some cell edge 
regions of myc-N-KIND (B) and the marked recruitment of myc-N-KIND-WH2 product to invadosomes (C). Note that myc-
WH2-Cter accumulated at invadosomes (D) by contrast to the Spire-1 HA-Cter truncate (E), Scale bar: 10 μm.
Fig. S4. Rab3A is up-regulated in Src+ fibroblasts and pre-Osteoclasts and co-localizes with Spire-1-positive invadosomes and 
rings. (A) Whole cell extracts from 106 of 3T3-WT, 3T3-Src+ and pre-Osteoclast Src+ cells were analysed by Western blot 
using anti-Rab3A antibodies. Level of expression was quantified with ImageJ software using GAPDH protein as reference 
(Histograms, data are from 2 different cell extracts). Molecular weights are indicated in kDa. (B) 3T3-Src+ cells were stained 
with anti-Rab3A antibodies (green) and phalloidin to detect F-actin (red). Framed areas 1 and 2 in the merge image are 
zoomed in right panels 1 and 2. Note the enrichment of Rab3A-positive vesicles at invadosomes (frame 1) and at the ring 
(frame 2), scale bar: 10 μm. (C) 3T3-Src+ cells transiently expressing either GFP or GFP in fusion with different Rabs (green) 
as indicated were stained to detect F-actin (red). Framed areas are zoomed as additional insets below the corresponding 
panels.
Fig. S5. Myc Spire-1 partially overlaps with both GFP-Rab8A and MT1-MMP-mC cytoplasmic vesicles while they distribute 
separately at invadosomes in Src+ fibroblasts after transient transfection. (A) Triple immunofluorescent labeling of 
Rab8A (GFP tagged, green), myc-Spire-1 (anti-myc antibodies, red) and F-actin (Phalloidin, blue) Arrows show individual 
cytoplasmic GFP-tab8A and myc-Spire-1-positive vesicles. Framed area shown in the merge image is zoomed in the bottom 
panel focusing on invadosomes and a rosette. (B) Double fluorescent labeling of MTP1-MMP-mC (red) and myc-Spire-1 (anti-
myc antibodies, red); note the delivery of the protease at the membrane surrounding the myc-Spire-1-positive invadosomes 
and rosettes. Frame area in the merge images are magnified in insets at the bottom of the panel. Scale bar: 10 μm
Table S1. List of primers used for PCR and cloning procedures
tGene 	   PCR Primer sequences 
 
	  
ARP3 	   Forward-GAGAGACCGAGAAGTAGGAATCCC 
Reverse-CTCAGGCGTGGAAGCCAGC 
	  
Spir-1 	   Forward- CTATGGTGAATGGAGGTTTGACATC 
Reverse – GGCCTGGCGAGGACATGTAGAAAG) 
	  
	   	   	   	  
 
Recipient 
vector 
 
 
Insert 
(amino acid 
position) 
 
 
PCR Primer sequences 
	  
 
Cloning 
sites 
	  
pCDNA3-
myc 
 
Full length 
1-756AA 
 
Forward- GC GGA TCC ATG GCT CAG GCG GCT GGC CCG 
Reverse- CG CTC GAG GAT CTC ACT GAT CGT CCT CTC T 
 
BamH1/Xho1 
 
pEGFP-C3 
 
Full length 
1-756AA 
 
Forward-CCGCTCGAGATGGCTCAGGCGGCTGGCCCG  
Reverse-GCTCTAGATCAGATCTCACTGATCGTCCTCTCT  
 
Xho1/Xba1 
 
pCS2-MT-
myc 
 
WH2 
268-480AA 
 
Forward-CCGCTCGAGGACTGGGCACGATTCTGGGTAC  
Reverse-GCTCTAGATCAGCTGCTGCTGCTGGTCGAC  
 
Xho1/Xba1 
 
pCS2-MT-
myc 
 
C-terminal 
556-756AA 
 
Forward-CCGCTCGAGCTCGCTCTTACTGTGGAAGAAGTG 
Reverse-GCTCTAGATCAGATCTCACTGATCGTCCTCTCT 
 
Xho1/Xba1 
 
pCS2-MT-
myc 
 
WH2-
Cterminal 
268-756AA 
 
Forward- CCGCTCGAGGACTGGGCACGATTCTGGGTAC 
Reverse-GCTCTAGATCAGATCTCACTGATCGTCCTCTCT 
 
Xho1/Xba1 
 
pCS2-HA 
 
C-terminal 
556-756AA 
 
Forward-CCGGAATTCCTCGCTCTTACTGTGGAAGAAGTG 
Reverse-GCTCTAGATCAGATCTCACTGATCGTCCTCTCT 
 
EcoR1/Xba1 
 
pCS2-MT-
myc 
 
N-KIND 
1-230AA 
 
Sub-cloning from pGEX6p3-KIND  
 
 
BamH1/Xho1 
 
pCS2-MT-
myc 
 
N-KIND-
WH2 
1-460AA 
 
Sub-cloning from pGEX6p3-KINDWH2  
 
 
BamH1/Xho1 
 
pET2817-
hGST 
N-KIND 
1-230 AA 
Forward 
CAGTCAGGAGCCATGGCTCAGGCGGCTGGCCCG 
Reverse 
AGTCAGTTAGGATCCGAGCTCCATTGTTTCTGCAAACAG 
 
NcoI/BamH1 
 
pET2817-
hGST 
C-terminal 
389-756AA 
Forward 
CAGTCAGGAGCCATGGTTAGACGTAGCAGATTAGCAATGC 
Reverse 
AGTCTGTTAGGATCCGATCTCACTGATCGTCCTCTCTGA 
NcoI/BamH1 
 
	  
	  
SupTable 1: Lagal et al. 
	  
	  
	  
Table S2. List of antibodies used for in situ and biochemical analysis
 
Antibody 
 
 
Dilution in 
Western Blot  
 
Dilution for 
IFA 
 
Source 
Rabbit anti-Spire-1 1/1000  K-19, Santa Cruz Biotechnology 
Inc.Heidelberg, Germany 
Rabbit anti-Rab3A 1/2000 1/100 Synaptic Systems, Goettingen, 
Germany 
Mouse anti-GAPDH 1/20000  Clone 6-C5, Ambion® Life Technologies, 
Saint Aubin, France 
Rabbit anti-N-KIND-Spire-1 1/1000 1/100 Amino acid 1-230, Eurogentec, Angers, 
France 
Mouse anti-c-myc 1/3000 1/200 Clone-9E10, Santa Cruz Biotechnology 
Inc.Heidelberg, Germany 
Rat anti-HA 1/4000 1/600 Clone-3F10, Roche 
Mouse anti-cortactin 1/5000 1/100 Clone-4F11, Cell Signaling 
Rabbit anti-Src 
phosphorylated (pY418) 
 1/200 Cell Signaling 
Mouse anti-Dia1 1/1000  Clone 51, BD Transduction laboratories, Pont 
de Claix, France 
Mouse anti-p16 (ARP2/3 
subunit) 
1/1000  Clone-323H3, Synaptic Systems, Gottingen, 
Germany 
Mouse anti-Src 1/1000  Clone GD11, Millipore, Molsheim, France 
Mouse anti-actin 1/2000  Clone-C4, Sigma-Aldrich, St Quentin 
Fallaviers, France 
Mouse anti-GFP   Roche Diagnostic, Meylan, France 
Rabbit anti-GST 1/20000  Sigma-Aldrich, St Quentin Fallaviers, France 
Rabbit anti-Histidine 1/5000  Santa Cruz Biotechnology 
Inc.Heidelberg, Germany 
Mouse Ve-Cadherin  1/200 clone BV6 | MABT134, Millipore, Molsheim, 
France 
HRP conjugated goat anti-
rabbit 
1/10000-
1/20000 
 Pierce Fisher Scientific, Illkirch, France 
HRP conjugated goat anti -
mouse 
1/20000  Pierce Fisher Scientific, Illkirch, France 
Alexa Fluor-conjugated 
secondary antibodies 
	   1/1000 Invitrogen life Technology, saint Aubin, 
France 
	  
SupTable 2: Lagal et al.	  
Table S3. List and composition of buffers
Buffer Name Composition Use 
	  
A 
20 mM HEPES, 150 mM NaCl, 0.1% TX-100, 2 mM 
MgCl2, 1 mM EDTA, 10% glycerol, 2X protease 
inhibitors 
 
4°C, 20 min 
B 50 mM Tris-HCl, 150 mM NaCl, 1 mM DTT, 2X 
protease inhibitors, pH-8 
4°C, 30 min 
C 20 mM HEPES, 150 mM NaCl, 1 mM DTT, 10% 
glycerol, 1 mM EDTA, 1 mM MgCl2, pH-7.4 
	  
4°C, 20 min 
	  
D 
20 mM HEPES, 150 mM NaCl, 2 mM EDTA, 0.2 
mg/ml BSA, 10 mM MgCl2, 1 mM DTT and 2X 
protease inhibitors, pH-7.4 
	  
E 50 mM HEPES, 150 mM NaCl, 10 mM MgCl2, 0.2 
mg/ml BSA, 2X protease inhibitors, pH-7.5 
	  
4°C, 20 min 
	  
SupTable 3: Lagal et al.	  
